Form SC 13G HALOZYME THERAPEUTICS Filed by: BB BIOTECH AG
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140807/AB22922FZ22ROJZ2222T2ZXSKMT4OZ223262
Filed on: August 7, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Halozyme and Incyte sign drug delivery licensing agreement
- Russell Investments Canada Limited Announces Monthly Distributions for Exchange Traded Fund Series (“ETF Series”) and Exchange Traded Funds (“ETFs”)
- Halozyme Announces Global Collaboration and License Agreement with Incyte to Support the Development of Subcutaneous Formulations of INCA033989 Using its ENHANZE® Technology
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
13GSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
